Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-Generation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-Generation

Published:2016-02-16 Issue:4 Volume:39 Page:192-200
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Collet Jean-Philippe¹,Silvain Johanne¹,Kerneis Mathieu¹,Cuisset Thomas²,Meneveau Nicolas³,Boueri Ziad⁴,Barthélémy Olivier¹,Rangé Grégoire⁵,Cayla Guillaume⁶,Belle Eric Van⁷,Elhadad Simon⁸,Carrié Didier⁹,Caussin Christophe¹⁰,Rousseau Hélène¹¹¹²,Aubry Pierre¹³,Monségu Jacques¹⁴,Sabouret Pierre¹,O'Connor Stephen A.¹,Abtan Jérémie¹,Saint-Etienne Christophe¹⁵,Beygui Farzin¹⁶,Vicaut Eric¹¹¹²,Montalescot Gilles¹,

Affiliation:

1. Univ Paris 06 (UPMC), ACTION Study Group; Institut de Cardiologie, Hôpital Pitié-Salpêtrière (APHP); Paris France

2. Department of Cardiology; CHU La Timone; Marseille France

3. Department of Cardiology, CHU Jean Minjoz; Besançon France

4. Department of Cardiology, CH de Bastia; France

5. Department of Cardiology, Les Hôpitaux de Chartres; Le Coudray France

6. ACTION Study Group, Department of Cardiology, CHU Carémeau; Nîmes France

7. Department of Cardiology; Lille University Hospital; Lille France

8. Department of Cardiology; CH de Lagny-Marne la Vallée; Lagny-sur-Marne France

9. Department of Cardiology; CHU Rangueil; Toulouse France

10. Department of Cardiology; Institut Mutualiste Montsouris; Paris France

11. ACTION Study Group; Unité de Recherche Clinique-Hôpital Lariboisière (APHP); Paris France

12. Université Denis Diderot; Paris France

13. Department of Cardiology; Centre Hospitalier Bichat (APHP); Paris France

14. Department of cardiology; Groupe Hospitalier Mutualiste; Grenoble France

15. Department of Cardiology; CHU Trousseau; Tours France

16. ACTION Study Group; CHU Côte de Nacre; Caen France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference34 articles.

1. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents;Mauri;N Engl J Med,2014

2. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement;Garratt;Circulation.,2015

3. Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease;Stone;N Engl J Med,2010

4. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials [published correction appears in Lancet. 2013;382:1878];Stefanini;Lancet.,2013

5. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials;Stefanini;Eur Heart J.,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014–2019);Frontiers in Cardiovascular Medicine;2023-03-24

2. Current trends in optimal medical therapy after PCI and its influence on clinical outcomes in China;BMC Cardiovascular Disorders;2021-05-26

3. Weighing the potential late benefits versus early hazard associated with bioresorbable vascular scaffolds in percutaneous coronary interventions: a Markov decision analytic model;Coronary Artery Disease;2020-05

4. Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis;Yonsei Medical Journal;2020

5. Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention;Coronary Artery Disease;2019-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3